Inbenta Reports Strong 1H 2025 Growth: New Logo Wins, Increased Customer Usage, and Improved Profitability
This increase in usage highlights the growing reliance of Inbenta's enterprise clients on its AI orchestration platform to power both customer and employee experiences. Enterprise integrations and customer-specific deployments also rose by 54% year-over-year, further demonstrating the platform's scalability and adaptability across complex environments.
Along with this rapid growth, Inbenta has significantly improved its profitability — meeting internal targets by using its AI to streamline productivity across the organization, while continuing to invest in innovation and customer success, including a major new platform release planned for later this year.
'We're proud to see strong growth across new logos and deeper usage from our existing customer base,' said Melissa Solis, CEO of Inbenta. 'Even more importantly, we achieved this while strengthening our financial foundation. It's a testament to our team's focus, our technology's maturity, and the value we're delivering to some of the world's leading enterprises.'
Inbenta's AI platform helps companies become AI-ready and launch value-driven solutions, providing them with the tools they need to measure and optimize performance. By enabling continuous improvement and scalable impact, Inbenta helps organizations harness AI to create meaningful, efficient connections that proactively boost customer satisfaction, enhance employee productivity, and drive real business growth.
Inbenta is well-positioned for continued momentum as it looks to accelerate its growth trajectory in the second half of 2025 and beyond.
About Inbenta
Inbenta is a global innovator in AI-powered customer and employee experience solutions. Its enterprise AI platform provides personalized, omnichannel support 24/7 through AI Agents that automate interactions and allow human workforces to focus on high-value initiatives. Inbenta enhances engagement, reduces costs, and boosts satisfaction. With deployments in over 100 languages across global enterprises in financial services, e-commerce, government, insurance, technology, healthcare, and travel, Inbenta processes over 2 billion interactions each year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
11 minutes ago
- Globe and Mail
Securities Lawsuit Alert: Lockheed Martin Corporation (LMT) Investors - Contact Levi & Korsinsky Before September 26, 2025
New York, New York--(Newsfile Corp. - August 14, 2025) - If you suffered a loss on your Lockheed Martin Corporation (NYSE: LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Lockheed Martin Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 23, 2024 and July 21, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Lockheed Martin lacked effective internal controls regarding its purportedly risk adjusted contracts including the reporting of its risk adjusted profit booking rate; (2) Lockheed Martin lacked effective procedures to perform reasonably accurate comprehensive reviews of program requirements, technical complexities, schedule, and risks; (3) Lockheed Martin overstated its ability to deliver on its contract commitments in terms of cost, quality and schedule; (4) as a result, the Company was reasonably likely to report significant losses; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Lockheed Martin Corporation stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
11 minutes ago
- Globe and Mail
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) Investors - Lead Plaintiff Deadline on August 25, 2025
New York, New York--(Newsfile Corp. - August 14, 2025) - If you suffered a loss on your Hims & Hers Health, Inc. (NYSE: HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Hims & Hers Health, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between April 29, 2025 and June 23, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy(R) that put patient safety at risk;" (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Hims & Hers Health, Inc. stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
11 minutes ago
- Globe and Mail
Securities Lawsuit Alert: Petco Health and Wellness Company, Inc. (WOOF) - Contact Levi & Korsinsky Before August 29, 2025
New York, New York--(Newsfile Corp. - August 14, 2025) - If you suffered a loss on your Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Petco Health and Wellness Company, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 14, 2021 and June 5, 2025. CASE DETAILS: (i) Petco's pandemic-related tailwinds were unsustainable, as was its business model of selling primarily premium and/or high-grade pet food; (ii) accordingly, the strength of Petco's differentiated product strategy was overstated; (iii) defendants downplayed the true scope and severity of the foregoing issues, the magnitude of changes needed to rectify those issues, and the likely negative impacts of their mitigation strategy on Petco's comparable sales metric; (iv) accordingly, defendants overstated Petco's ability to deliver sustainable, profitable growth; and (v) as a result, defendants' public statements were materially false and misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in Petco stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
